Large gap with delayed quotes
|
Last quote
11/04/2025
-
23:20:00
|
Bid
11/04/2025 -
21:59:59
|
Bid Volume |
Ask
11/04/2025 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
18.03
+0.15
(
+0.84% )
|
18.03
|
700 |
18.04
|
3,500 |
Analysis date: 31.10.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 28.10.2025.
Interest
Very strong
Very strong
Four stars since 24.10.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 24.10.2025 at a price of 18.49.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 14.10.2025.
4wk Rel Perf
3.91%
3.91%
The four-week dividend-adjusted overperformance versus SP500 is 3.91%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 11.07.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.03%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.91%.
Mkt Cap in $bn
1.26
1.26
With a market capitalization <$2bn, HEALTHCARE SVCS is considered a small-cap stock.
G/PE Ratio
1.02
1.02
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
17.54
17.54
The estimated PE is for the year 2026.
LT Growth
17.91%
17.91%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
4
4
Over the last seven weeks, an average of 4 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
142
142
For 1% of index variation, the stock varies on average by 1.42%.
Correlation
0.40
0.40
Stock movements are strongly independent of index variations.
Value at Risk
4.29
4.29
The value at risk is estimated at USD 4.29. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
18.03.2009
18.03.2009